Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
H.C. Wainwright to hold a virtual conference » 04:55
09/15/21
09/15
04:55
09/15/21
04:55
ABUS

Arbutus Biopharma

$4.25 /

-0.005 (-0.12%)

, ACER

Acer Therapeutics

$2.53 /

-0.1 (-3.80%)

, ACET

Adicet Bio

$7.28 /

-0.47 (-6.06%)

, CIDM

Cinedigm

$2.16 /

+0.06 (+2.86%)

, TMDI

Titan Medical

$1.59 /

-0.025 (-1.55%)

, SLGG

Super League Gaming

$3.60 /

-0.21 (-5.51%)

, SLRX

Salarius Pharmaceuticals

$1.03 /

+ (+0.00%)

, SMLR

Semler Scientific

$106.60 /

-0.43 (-0.40%)

, ZYNE

Zynerba

$4.31 /

-0.135 (-3.04%)

, TARA

Protara Therapeutics

$7.19 /

-0.46 (-6.01%)

, TCON

Tracon Pharmaceuticals

$3.73 /

-0.11 (-2.86%)

, RUBY

Rubius Therapeutics

$19.44 /

-0.68 (-3.38%)

, PLSE

Pulse Biosciences

$20.46 /

-0.26 (-1.25%)

, PNT

Point Biopharma

$9.34 /

+0.31 (+3.43%)

, IMRA

Imara

$4.12 /

-0.14 (-3.29%)

, IMAB

I-Mab

$68.57 /

+0.32 (+0.47%)

, KBNT

Kubient

$3.50 /

+0.07 (+2.04%)

, LPTX

Leap Therapeutics

$1.79 /

+0.01 (+0.56%)

, LUMO

Lumos Pharma

$10.10 /

-0.45 (-4.27%)

, LYRA

Lyra Therapeutics

$8.18 /

-0.37 (-4.33%)

, EDAP

EDAP TMS

$6.25 /

+0.255 (+4.25%)

, EXEL

Exelixis

$20.14 /

-0.11 (-0.54%)

, GMTX

Gemini Therapeutics

$4.54 /

-0.045 (-0.98%)

, BLU

Bellus Health

$5.56 /

+0.79 (+16.56%)

, CGRN

Capstone Green Energy

$4.45 /

-0.06 (-1.33%)

, DYAI

Dyadic International

$5.34 /

-0.41 (-7.13%)

, AGRI

AgriFORCE Growing Systems

$2.32 /

-0.19 (-7.57%)

, ANEB

Anebulo Pharmaceuticals

$6.96 /

-0.06 (-0.85%)

, VIVE

Viveve

$2.39 /

-0.07 (-2.85%)

, ZIOP

Ziopharm

$1.63 /

-0.195 (-10.68%)

23rd Annual Global…

23rd Annual Global Investment Virtual Conference to be held on September 13-15.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

ZIOP Ziopharm
$1.63 /

-0.195 (-10.68%)

VIVE Viveve
$2.39 /

-0.07 (-2.85%)

TMDI Titan Medical
$1.59 /

-0.025 (-1.55%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

SLGG Super League Gaming
$3.60 /

-0.21 (-5.51%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

DYAI Dyadic International
$5.34 /

-0.41 (-7.13%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

BLU Bellus Health
$5.56 /

+0.79 (+16.56%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

06/10/21 William Blair
Acer's increased pipeline visibility is encouraging, says William Blair
ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
TMDI Titan Medical
$1.59 /

-0.025 (-1.55%)

04/06/21 Oppenheimer
Opco starts 'attractive micro-cap play' Titan Medical with Outperform
04/06/21 Oppenheimer
Titan Medical initiated with an Outperform at Oppenheimer
SLGG Super League Gaming
$3.60 /

-0.21 (-5.51%)

05/27/21 H.C. Wainwright
Super League Gaming initiated with a Buy at H.C. Wainwright
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 H.C. Wainwright
Salarius Pharmaceuticals initiated with a Buy at H.C. Wainwright
SMLR Semler Scientific
$106.60 /

-0.43 (-0.40%)

05/04/21 B. Riley
Semler Scientific price target raised to $151 from $147 at B. Riley
04/27/21 B. Riley
Semler Scientific transferred with Buy, $147 target at B. Riley
03/02/21 B. Riley
Semler Scientific price target raised to $147 from $121 at B. Riley Securities
02/25/21 B. Riley
Semler Scientific price target raised to $121 from $100 at B. Riley Securities
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

07/26/21 Stephens
Pulse Biosciences a 'compelling and durable story,' says Stephens
07/26/21 Stephens
Pulse Biosciences initiated with an Overweight at Stephens
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

07/29/21 Cowen
Cowen starts Point Biopharma at Outperform
07/29/21 Cowen
Point Biopharma initiated with an Outperform at Cowen
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/26/21 Piper Sandler
Point Biopharma initiated with an Overweight at Piper Sandler
IMRA Imara
$4.12 /

-0.14 (-3.29%)

08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
KBNT Kubient
$3.50 /

+0.07 (+2.04%)

08/17/21 Maxim
Kubient price target lowered to $9 from $13 at Maxim
03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
05/17/21 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

08/05/21 Piper Sandler
Lumos shares trading below cash, says Piper Sandler
07/22/21 Roth Capital
Lumos Pharma price target lowered to $35 from $51 at Roth Capital
07/21/21 Piper Sandler
Piper says Lumos Pharma's OraGrowtH210 trial delay 'not a problem'
07/21/21 H.C. Wainwright
Lumos Pharma price target lowered to $27 from $34 at H.C. Wainwright
LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

06/23/21 Stifel
Gemini's negative stock reaction to GEM103 data overdone, says Stifel
04/08/21 SVB Leerink
SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform
04/08/21 SVB Leerink
Gemini Therapeutics initiated with an Outperform at SVB Leerink
03/03/21 Jefferies
Gemini Therapeutics initiated with a Buy at Jefferies
BLU Bellus Health
$5.56 /

+0.79 (+16.56%)

09/14/21 BTIG
Bellus Health price target raised to $13 from $9 at BTIG
09/14/21 H.C. Wainwright
Bellus Health price target raised to $14 from $10 at H.C. Wainwright
07/29/21 BTIG
Bellus Health initiated with a Buy at BTIG
01/29/21 RBC Capital
Bellus Health initiated with an Outperform at RBC Capital
CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

DYAI Dyadic International
$5.34 /

-0.41 (-7.13%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ANEB Anebulo Pharmaceuticals
$6.96 /

-0.06 (-0.85%)

05/25/21 Benchmark
Anebulo Pharmaceuticals initiated with a Buy at Benchmark
VIVE Viveve
$2.39 /

-0.07 (-2.85%)

01/29/21 Alliance Global Partners
Viveve initiated with a Buy at Alliance Global Partners
ZIOP Ziopharm
$1.63 /

-0.195 (-10.68%)

08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/10/21 Lake Street
Ziopharm price target lowered to $3.50 from $7 at Lake Street
08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/09/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

  • 14
    Jul
  • 18
    Jun
  • 07
    May
  • 23
    Apr
  • 17
    Mar
  • 04
    Mar
  • 10
    Feb
  • 09
    Feb
  • 13
    Jan
  • 06
    Jan
  • 23
    Dec
  • 20
    Oct
  • 22
    Sep
  • 24
    Sep
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

ANEB Anebulo Pharmaceuticals
$6.96 /

-0.06 (-0.85%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

Tuesday
Conference/Events
H.C. Wainwright to hold a virtual conference » 09:30
09/14/21
09/14
09:30
09/14/21
09:30
ABUS

Arbutus Biopharma

$4.25 /

-0.145 (-3.30%)

, ACER

Acer Therapeutics

$2.61 /

-0.09 (-3.33%)

, ACET

Adicet Bio

$7.52 /

-0.16 (-2.08%)

, CIDM

Cinedigm

$2.10 /

+0.01 (+0.48%)

, TMDI

Titan Medical

$1.62 /

+0.05 (+3.19%)

, SLGG

Super League Gaming

$3.81 /

-0.08 (-2.06%)

, SLRX

Salarius Pharmaceuticals

$1.03 /

-0.025 (-2.37%)

, SMLR

Semler Scientific

$107.03 /

-2.72 (-2.48%)

, ZYNE

Zynerba

$4.44 /

-0.035 (-0.78%)

, TARA

Protara Therapeutics

$7.64 /

-0.12 (-1.55%)

, TCON

Tracon Pharmaceuticals

$3.85 /

-0.02 (-0.52%)

, RUBY

Rubius Therapeutics

$20.12 /

-0.83 (-3.96%)

, PLSE

Pulse Biosciences

$20.78 /

-0.14 (-0.67%)

, PNT

Point Biopharma

$9.15 /

-2.33 (-20.30%)

, IMRA

Imara

$4.26 /

-0.14 (-3.18%)

, IMAB

I-Mab

$68.25 /

-3.75 (-5.21%)

, KBNT

Kubient

$3.43 /

+0.13 (+3.94%)

, LPTX

Leap Therapeutics

$1.78 /

+0.31 (+21.16%)

, LUMO

Lumos Pharma

$10.64 /

-0.6 (-5.34%)

, LYRA

Lyra Therapeutics

$8.45 /

+ (+0.00%)

, EDAP

EDAP TMS

$6.00 /

+0.005 (+0.08%)

, EXEL

Exelixis

$20.25 /

+0.275 (+1.38%)

, GMTX

Gemini Therapeutics

$4.59 /

-0.1 (-2.13%)

, BLU

Bellus Health

$4.77 /

+0.84 (+21.37%)

, CGRN

Capstone Green Energy

$4.52 /

+0.01 (+0.22%)

, DYAI

Dyadic International

$5.78 /

+0.04 (+0.70%)

, AGRI

AgriFORCE Growing Systems

$2.51 /

-0.04 (-1.57%)

, ANEB

Anebulo Pharmaceuticals

$7.02 /

+0.12 (+1.74%)

, VIVE

Viveve

$2.46 /

-0.03 (-1.20%)

, ZIOP

Ziopharm

$1.83 /

-0.075 (-3.95%)

23rd Annual Global…

23rd Annual Global Investment Virtual Conference to be held on September 13-15.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

ZIOP Ziopharm
$1.83 /

-0.075 (-3.95%)

VIVE Viveve
$2.46 /

-0.03 (-1.20%)

TMDI Titan Medical
$1.62 /

+0.05 (+3.19%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

SLGG Super League Gaming
$3.81 /

-0.08 (-2.06%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

DYAI Dyadic International
$5.78 /

+0.04 (+0.70%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

BLU Bellus Health
$4.77 /

+0.84 (+21.37%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

06/10/21 William Blair
Acer's increased pipeline visibility is encouraging, says William Blair
ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
TMDI Titan Medical
$1.62 /

+0.05 (+3.19%)

04/06/21 Oppenheimer
Opco starts 'attractive micro-cap play' Titan Medical with Outperform
04/06/21 Oppenheimer
Titan Medical initiated with an Outperform at Oppenheimer
SLGG Super League Gaming
$3.81 /

-0.08 (-2.06%)

05/27/21 H.C. Wainwright
Super League Gaming initiated with a Buy at H.C. Wainwright
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 H.C. Wainwright
Salarius Pharmaceuticals initiated with a Buy at H.C. Wainwright
SMLR Semler Scientific
$107.03 /

-2.72 (-2.48%)

05/04/21 B. Riley
Semler Scientific price target raised to $151 from $147 at B. Riley
04/27/21 B. Riley
Semler Scientific transferred with Buy, $147 target at B. Riley
03/02/21 B. Riley
Semler Scientific price target raised to $147 from $121 at B. Riley Securities
02/25/21 B. Riley
Semler Scientific price target raised to $121 from $100 at B. Riley Securities
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

07/26/21 Stephens
Pulse Biosciences a 'compelling and durable story,' says Stephens
07/26/21 Stephens
Pulse Biosciences initiated with an Overweight at Stephens
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

07/29/21 Cowen
Cowen starts Point Biopharma at Outperform
07/29/21 Cowen
Point Biopharma initiated with an Outperform at Cowen
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/26/21 Piper Sandler
Point Biopharma initiated with an Overweight at Piper Sandler
IMRA Imara
$4.26 /

-0.14 (-3.18%)

08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
KBNT Kubient
$3.43 /

+0.13 (+3.94%)

08/17/21 Maxim
Kubient price target lowered to $9 from $13 at Maxim
03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
05/17/21 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

08/05/21 Piper Sandler
Lumos shares trading below cash, says Piper Sandler
07/22/21 Roth Capital
Lumos Pharma price target lowered to $35 from $51 at Roth Capital
07/21/21 Piper Sandler
Piper says Lumos Pharma's OraGrowtH210 trial delay 'not a problem'
07/21/21 H.C. Wainwright
Lumos Pharma price target lowered to $27 from $34 at H.C. Wainwright
LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

06/23/21 Stifel
Gemini's negative stock reaction to GEM103 data overdone, says Stifel
04/08/21 SVB Leerink
SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform
04/08/21 SVB Leerink
Gemini Therapeutics initiated with an Outperform at SVB Leerink
03/03/21 Jefferies
Gemini Therapeutics initiated with a Buy at Jefferies
BLU Bellus Health
$4.77 /

+0.84 (+21.37%)

09/14/21 BTIG
Bellus Health price target raised to $13 from $9 at BTIG
09/14/21 H.C. Wainwright
Bellus Health price target raised to $14 from $10 at H.C. Wainwright
07/29/21 BTIG
Bellus Health initiated with a Buy at BTIG
01/29/21 RBC Capital
Bellus Health initiated with an Outperform at RBC Capital
CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

DYAI Dyadic International
$5.78 /

+0.04 (+0.70%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ANEB Anebulo Pharmaceuticals
$7.02 /

+0.12 (+1.74%)

05/25/21 Benchmark
Anebulo Pharmaceuticals initiated with a Buy at Benchmark
VIVE Viveve
$2.46 /

-0.03 (-1.20%)

01/29/21 Alliance Global Partners
Viveve initiated with a Buy at Alliance Global Partners
ZIOP Ziopharm
$1.83 /

-0.075 (-3.95%)

08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/10/21 Lake Street
Ziopharm price target lowered to $3.50 from $7 at Lake Street
08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/09/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

  • 14
    Jul
  • 18
    Jun
  • 07
    May
  • 23
    Apr
  • 17
    Mar
  • 04
    Mar
  • 10
    Feb
  • 09
    Feb
  • 13
    Jan
  • 06
    Jan
  • 23
    Dec
  • 20
    Oct
  • 22
    Sep
  • 24
    Sep
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

ANEB Anebulo Pharmaceuticals
$7.02 /

+0.12 (+1.74%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

Over a month ago
Earnings
Tracon Pharmaceuticals reports Q2 EPS (58c,) consensus (31c) » 16:29
08/11/21
08/11
16:29
08/11/21
16:29
TCON

Tracon Pharmaceuticals

$3.68 /

-0.05 (-1.34%)

Cash, cash equivalents…

Cash, cash equivalents and short-term investments were $25.6 million at June 30 , compared to $36.1 million at December 31, 2020. The cash balance at June 30, 2021, does not include the proceeds from the $15 million underwritten public offering in July, which extends the Company's cash runway into 2023. .We remain on track to announce interim efficacy data from the pivotal ENVASARC trial by the end of this year and final data in 2022," said Charles Theuer, M.D., Ph.D., President and CEO of TRACON. "Last week the IDMC recommended the study proceed as planned following review of interim safety data and we will continue to focus our efforts on enrolling this pivotal trial. Following our recent public offering, our balance sheet provides us with cash runway into 2023."

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$3.68 /

-0.05 (-1.34%)

TCON Tracon Pharmaceuticals
$3.68 /

-0.05 (-1.34%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$3.68 /

-0.05 (-1.34%)

TCON Tracon Pharmaceuticals
$3.68 /

-0.05 (-1.34%)

Hot Stocks
Tracon announce results of second IDMC review of ENVASARC » 08:09
08/09/21
08/09
08:09
08/09/21
08:09
TCON

Tracon Pharmaceuticals

$3.62 /

-0.06 (-1.63%)

TRACON Pharmaceuticals…

TRACON Pharmaceuticals announced that the Independent Data Monitoring Committee, or IDMC, for the ENVASARC pivotal trial has recommended that the trial proceed as planned following the review of 12 week safety data from more than 20 patients enrolled into the trial as of May 2021. The safety data reviewed included data from more than 10 patients enrolled into cohort A of treatment with single agent envafolimab and more than 10 patients enrolled into cohort B of treatment with envafolimab and Yervoy. "Envafolimab continues to be well tolerated as a single agent and when combined with Yervoy in refractory sarcoma patients who are enrolled in the ENVASARC trial. We remain on track for the Independent Data Monitoring Committee to review interim efficacy data in the fourth quarter of this year," said James Freddo, M.D., TRACON's Chief Medical Officer.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$3.62 /

-0.06 (-1.63%)

TCON Tracon Pharmaceuticals
$3.62 /

-0.06 (-1.63%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$3.62 /

-0.06 (-1.63%)

TCON Tracon Pharmaceuticals
$3.62 /

-0.06 (-1.63%)

Conference/Events
Tracon Pharmaceuticals management to meet virtually with Oppenheimer » 05:55
08/02/21
08/02
05:55
08/02/21
05:55
TCON

Tracon Pharmaceuticals

$3.76 /

-0.065 (-1.70%)

Virtual Meeting to be…

Virtual Meeting to be held on July 30 and August 2 hosted by Oppenheimer.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$3.76 /

-0.065 (-1.70%)

TCON Tracon Pharmaceuticals
$3.76 /

-0.065 (-1.70%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$3.76 /

-0.065 (-1.70%)

TCON Tracon Pharmaceuticals
$3.76 /

-0.065 (-1.70%)

Conference/Events
Tracon Pharmaceuticals management to meet virtually with Oppenheimer » 04:55
07/30/21
07/30
04:55
07/30/21
04:55
TCON

Tracon Pharmaceuticals

$3.81 /

-0.01 (-0.26%)

Virtual Meeting to be…

Virtual Meeting to be held on July 30 and August 2 hosted by Oppenheimer.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$3.81 /

-0.01 (-0.26%)

TCON Tracon Pharmaceuticals
$3.81 /

-0.01 (-0.26%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$3.81 /

-0.01 (-0.26%)

TCON Tracon Pharmaceuticals
$3.81 /

-0.01 (-0.26%)

Conference/Events
Tracon Pharmaceuticals management to meet virtually with Oppenheimer » 09:33
07/29/21
07/29
09:33
07/29/21
09:33
TCON

Tracon Pharmaceuticals

$3.82 /

+0.05 (+1.33%)

Virtual Meeting to be…

Virtual Meeting to be held on July 30 and August 2 hosted by Oppenheimer.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$3.82 /

+0.05 (+1.33%)

TCON Tracon Pharmaceuticals
$3.82 /

+0.05 (+1.33%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$3.82 /

+0.05 (+1.33%)

TCON Tracon Pharmaceuticals
$3.82 /

+0.05 (+1.33%)

On The Fly
Fly Intel: Pre-market Movers » 08:57
07/22/21
07/22
08:57
07/22/21
08:57
IGC

India Globalization Capital

$1.46 /

+0.03 (+2.10%)

, NRXP

NRx Pharmaceuticals

$10.12 /

-0.26 (-2.50%)

, T

AT&T

$27.88 /

-0.045 (-0.16%)

, DHR

Danaher

$279.74 /

-3.935 (-1.39%)

, BX

Blackstone

$105.82 /

+2.02 (+1.95%)

, BIIB

Biogen

$323.13 /

+0.42 (+0.13%)

, DPZ

Domino's Pizza

$470.37 /

-5.005 (-1.05%)

, DHI

D.R. Horton

$91.49 /

+2.43 (+2.73%)

, LUV

Southwest

$53.12 /

+1.68 (+3.27%)

, AAL

American Airlines

$21.40 /

+0.84 (+4.09%)

, CLF

Cleveland-Cliffs

$21.19 /

+1.135 (+5.66%)

, LVS

Las Vegas Sands

$49.46 /

+1.68 (+3.52%)

, TCON

Tracon Pharmaceuticals

$4.93 /

-0.24 (-4.64%)

Check out this morning's…

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

T AT&T
$27.88 /

-0.045 (-0.16%)

NRXP NRx Pharmaceuticals
$10.12 /

-0.26 (-2.50%)

LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

LUV Southwest
$53.12 /

+1.68 (+3.27%)

IGC India Globalization Capital
$1.46 /

+0.03 (+2.10%)

DPZ Domino's Pizza
$470.37 /

-5.005 (-1.05%)

DHR Danaher
$279.74 /

-3.935 (-1.39%)

DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

BX Blackstone
$105.82 /

+2.02 (+1.95%)

BIIB Biogen
$323.13 /

+0.42 (+0.13%)

AAL American Airlines
$21.40 /

+0.84 (+4.09%)

IGC India Globalization Capital
$1.46 /

+0.03 (+2.10%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
NRXP NRx Pharmaceuticals
$10.12 /

-0.26 (-2.50%)

T AT&T
$27.88 /

-0.045 (-0.16%)

07/22/21 RBC Capital
RBC Capital transfers coverage of AT&T with Sector Perform
07/19/21 MoffettNathanson
New pact with AT&T 'a windfall' for Dish, says MoffettNathanson
07/12/21 Bernstein
Charter downgraded to Market Perform from Outperform at Bernstein
07/09/21 Tigress Financial
AT&T shares have upside to $36 over next year, says Tigress Financial
DHR Danaher
$279.74 /

-3.935 (-1.39%)

07/16/21 Benchmark
Danaher initiated with a Buy at Benchmark
07/13/21 Barclays
Danaher price target raised to $310 from $300 at Barclays
06/04/21 Jefferies
Danaher selloff after Abbott warning overdone, says Jefferies
04/26/21 Barclays
Danaher price target raised to $300 from $265 at Barclays
BX Blackstone
$105.82 /

+2.02 (+1.95%)

07/15/21 Citi
Blackstone price target raised to $103.50 from $100 at Citi
07/12/21 Deutsche Bank
Blackstone price target raised to $86 from $79 at Deutsche Bank
07/12/21 Citi
Blackstone price target raised to $100 from $91 at Citi
06/07/21 MoffettNathanson
QTS Realty buyout 'very appealing result,' says MoffettNathanson
BIIB Biogen
$323.13 /

+0.42 (+0.13%)

07/19/21 Baird
Biogen survey highlights uncertainty around Aduhelm launch, says Baird
07/19/21 Piper Sandler
Doctors see 'robust' uptake of Biogen's Aduhelm, says Piper Sandler
07/19/21 Goldman Sachs
Option Care Health upgraded to Buy from Neutral at Goldman Sachs
07/13/21 Oppenheimer
Prothena price target raised to $76 from $54 at Oppenheimer
DPZ Domino's Pizza
$470.37 /

-5.005 (-1.05%)

07/19/21 Stifel
Domino's Pizza price target raised to $485 from $435 at Stifel
07/16/21 Wedbush
Domino's Pizza price target raised to $520 from $480 at Wedbush
07/14/21 Wells Fargo
Domino's Pizza price target raised to $446 from $420 at Wells Fargo
07/12/21 RBC Capital
Domino's Pizza price target raised to $515 from $466 at RBC Capital
DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

07/19/21 BTIG
D.R. Horton price target lowered to $117 from $124 at BTIG
07/15/21 Barclays
D.R. Horton price target lowered to $109 from $114 at Barclays
07/08/21
Fly Intel: Top five analyst downgrades
07/08/21 RBC Capital
D.R. Horton downgraded to Sector Perform from Outperform at RBC Capital
LUV Southwest
$53.12 /

+1.68 (+3.27%)

06/09/21 MKM Partners
Southwest initiated with a Buy at MKM Partners
04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
AAL American Airlines
$21.40 /

+0.84 (+4.09%)

07/14/21 Citi
American Airlines upgraded to Neutral from Sell at Citi
06/09/21 MKM Partners
American Airlines initiated with a Buy at MKM Partners
06/09/21 MKM Partners
American Airlines initiated with a Buy at MKM Partners
04/23/21 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

07/08/21 Argus
Argus starts Cleveland-Cliffs with a Buy, sees shares attractively valued
07/08/21 Argus
Cleveland-Cliffs initiated with a Buy at Argus
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
06/16/21
Fly Intel: Top five analyst initiations
LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

04/22/21 Credit Suisse
Las Vegas Sands price target raised to $69 from $58 at Credit Suisse
04/20/21 JPMorgan
Las Vegas Sands should be bought ahead of sentiment turn, says JPMorgan
04/19/21 Jefferies
Las Vegas Sands price target raised to $71 from $66 at Jefferies
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

T AT&T
$27.88 /

-0.045 (-0.16%)

LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

LUV Southwest
$53.12 /

+1.68 (+3.27%)

DPZ Domino's Pizza
$470.37 /

-5.005 (-1.05%)

DHR Danaher
$279.74 /

-3.935 (-1.39%)

DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

BX Blackstone
$105.82 /

+2.02 (+1.95%)

BIIB Biogen
$323.13 /

+0.42 (+0.13%)

AAL American Airlines
$21.40 /

+0.84 (+4.09%)

  • 09
    Feb
  • 10
    Nov
T AT&T
$27.88 /

-0.045 (-0.16%)

LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

LUV Southwest
$53.12 /

+1.68 (+3.27%)

IGC India Globalization Capital
$1.46 /

+0.03 (+2.10%)

DHR Danaher
$279.74 /

-3.935 (-1.39%)

DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

BX Blackstone
$105.82 /

+2.02 (+1.95%)

BIIB Biogen
$323.13 /

+0.42 (+0.13%)

AAL American Airlines
$21.40 /

+0.84 (+4.09%)

T AT&T
$27.88 /

-0.045 (-0.16%)

NRXP NRx Pharmaceuticals
$10.12 /

-0.26 (-2.50%)

LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

LUV Southwest
$53.12 /

+1.68 (+3.27%)

IGC India Globalization Capital
$1.46 /

+0.03 (+2.10%)

DPZ Domino's Pizza
$470.37 /

-5.005 (-1.05%)

DHR Danaher
$279.74 /

-3.935 (-1.39%)

DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

BX Blackstone
$105.82 /

+2.02 (+1.95%)

BIIB Biogen
$323.13 /

+0.42 (+0.13%)

AAL American Airlines
$21.40 /

+0.84 (+4.09%)

T AT&T
$27.88 /

-0.045 (-0.16%)

LVS Las Vegas Sands
$49.46 /

+1.68 (+3.52%)

LUV Southwest
$53.12 /

+1.68 (+3.27%)

IGC India Globalization Capital
$1.46 /

+0.03 (+2.10%)

DHR Danaher
$279.74 /

-3.935 (-1.39%)

DHI D.R. Horton
$91.49 /

+2.43 (+2.73%)

CLF Cleveland-Cliffs
$21.19 /

+1.135 (+5.66%)

BX Blackstone
$105.82 /

+2.02 (+1.95%)

BIIB Biogen
$323.13 /

+0.42 (+0.13%)

AAL American Airlines
$21.40 /

+0.84 (+4.09%)

Syndicate
Tracon Pharmaceuticals increases bought-deal offering of common stock to $15M » 07:12
07/22/21
07/22
07:12
07/22/21
07:12
TCON

Tracon Pharmaceuticals

$4.93 /

-0.24 (-4.64%)

TRACON Pharmaceuticals…

TRACON Pharmaceuticals announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 3,926,702 shares of common stock of the Company at a price to the public of $3.82 per share. The closing of the public offering is expected to occur on or about July 26, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The prior offering size was $10M.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

Syndicate
Tracon Pharmaceuticals announces $10M bought deal offering of common stock » 17:29
07/21/21
07/21
17:29
07/21/21
17:29
TCON

Tracon Pharmaceuticals

$4.93 /

-0.24 (-4.64%)

Tracon Pharmaceuticals…

Tracon Pharmaceuticals announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 2,617,802 shares of the company's common stock at a public offering price of $3.82 per share, less underwriting discounts and commissions. The offering is expected to close on or about July 26, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The gross proceeds of the offering are expected to be approximately $10M, prior to deducting underwriting discounts, commissions and estimated offering expenses and excluding the exercise of the underwriter's option to purchase additional shares. The company intends to use the net proceeds from this offering to support the continued clinical development of envafolimab, as well as for working capital and general corporate purposes.

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
TCON Tracon Pharmaceuticals
$4.93 /

-0.24 (-4.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.